- Document Type
- Rapid Review
- Review Code
- LAB041402 RR
- Question Submitted
- April 14, 2020
- Date Completed
- April 15, 2020
- Status
- 3. Completed
- Research Team
- Laboratory
- Document Type
- Rapid Review
- Review Code
- LAB041402 RR
- Question Submitted
- April 14, 2020
- Date Completed
- April 15, 2020
- Status
- 3. Completed
- Research Team
- Laboratory
- Key Findings
- The majority of patients (>50%) appear to seroconvert between 8-14 days following the onset of symptoms.
- Nearly all patients (>80%) seroconvert >15 days following the onset of symptoms.
- The IgM response is detected earlier (median 12 days) than the IgG response (median 14 days).
- Seroconversion appears to follow clinical recovery in most cases.
- Category
- Clinical Presentation
- Subject
- Antibodies
- Natural History
- Serology
- Population
- All
- Priority Level
- Level 2 completed within 8 hours
- Cite As
- Vanstone, J; Reeder, B; Duncan, V. At what time in the disease timeline of COVID-19 do antibodies develop? 2020 Apr 15; Document no.: LAB041402 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 4 p. (CEST rapid review report)
Related Documents
Less detail
